CDEK
← All drugs Report issue

amg 404

mAbexperimental

Clinical trial activity

6 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Apr 18, 2018 (NCT03296696)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04885998Phase 1Sep 27, 2021Amgen
NCT04727554Phase 1Apr 29, 2021Amgen
NCT04631601Phase 1Jan 23, 2021Amgen
NCT04524455Phase 1Oct 2, 2020Amgen
NCT03853109Phase 1Mar 5, 2019Amgen
NCT03296696Phase 1Apr 18, 2018Amgen
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AmgenFor profit6612018
1 organizations
Page 1 / 1